Source: Bhang Inc.
  • Bhang (BHNG) has closed a non-brokered private placement or aggregate gross proceeds of $1,218,107
  • The company issued 22,147,400 units priced at C$0.55 per unit
  • Proceeds will be used for general working capital purposes
  • Bhang offers a portfolio of over 50 master-chef-created cannabis, CBD and terpene products
  • Bhang Inc. (BHNG) opened trading at C$0.085 per share

Bhang (BHNG) has closed a non-brokered private placement or aggregate gross proceeds of $1,218,107.  

The company issued 22,147,400 units priced at C$0.55 per unit. Each unit consists of one subordinate voting share (SVS) and one half SVS purchase warrant. Each whole warrant entitles the holder to purchase one SVSat an exercise price of $0.10 for a period of 18 months.

The units issued are subject to a four-month hold period expiring on April 18, 2022. Proceeds will be used for general working capital purposes.

The company paid a cash finder’s fee of approximately $25,014 and 454,800 finder warrants.

Bhang, a global cannabis CPG brand company, offers a portfolio of over 50 master-chef-created cannabis, CBD and terpene products including gourmet chocolates, pre-rolls, CBD isolate, and Hempsticks™.

Bhang Inc. (BHNG) opened trading at C$0.085 per share.

More From The Market Online

Buzz on the Bullboards: Oil shock, biotech breakthroughs and new tech

Global equities lurched from rally to rout since the U.S.–Israel strikes on Iran ignited a regional war and shutdown of the Strait of Hormuz.

Cannabix’s Marijuana Breath Test hits the market

Cannabix (CSE:BLO) begins the commercial rollout for its Marijuana Breath Test, including deliveries to customers across numerous industries.
Stock Talk Cannabis Report image of cannabis plants and VW van

StockTalk | Cannabis Report: Relaunching business into the spring

Ascend Wellness Holdings, Inc. (CSE: AAWH.U / OTCQX:AAWH), a multi-state, vertically integrated cannabis operator, has relaunched...

Quit smoking with psychedelics? A new frontier for treatment — and investors

A new Johns Hopkins study found that a single dose of psilocybin, combined with therapy, helped smokers stay cigarette free at six months.